| Title |
Corticosteroids for pulmonary sarcoidosis
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2005
|
| DOI | 10.1002/14651858.cd001114.pub2 |
| Pubmed ID | |
| Authors |
N Shanthi Paramothayan, Toby J Lasserson, Paul Jones |
| Abstract |
Pulmonary sarcoidosis is a common condition with an unpredictable course. Oral (OCS) or inhaled steroids (ICS) are widely used in its treatment, but there is no consensus about when and in whom therapy should be initiated, what dose should be given and for how long. Corticosteroids given for several months have deleterious side-effects so it is important to know whether they have any maintained benefit in pulmonary sarcoidosis. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 112 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| Unknown | 110 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 14 | 13% |
| Student > Bachelor | 14 | 13% |
| Student > Master | 13 | 12% |
| Student > Ph. D. Student | 9 | 8% |
| Student > Postgraduate | 8 | 7% |
| Other | 19 | 17% |
| Unknown | 35 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 45% |
| Nursing and Health Professions | 9 | 8% |
| Immunology and Microbiology | 3 | 3% |
| Computer Science | 2 | 2% |
| Social Sciences | 2 | 2% |
| Other | 8 | 7% |
| Unknown | 38 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 July 2023.
All research outputs
#6,599,710
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#7,870
of 11,499 outputs
Outputs of similar age
#20,772
of 69,836 outputs
Outputs of similar age from Cochrane database of systematic reviews
#25
of 51 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 31st percentile – i.e., 31% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,836 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.